Skip to main content
Premium Trial:

Request an Annual Quote

Cogenics Using 454 Sequencing in Crop Collaboration

NEW YORK (GenomeWeb News) – Cogenics and Roche subsidiary 454 Life Sciences will collaborate to develop SNPs for the plant breeder Limagrain that could be used to engineer better crops including wheat, Cogenics’ parent company Clinical Data said today.
 
Under the agreement, Cogenics will develop a genome complexity reduction assay to select gene-rich portions of a crop genome across multiple variants of the species.
 
Clinical Data said Cogenics will work with 454 to sequence around 2Gb of the wheat genome using the GS-FLX sequencer. The sequencing is the first step in a two-stage process, through which the companies will identify molecular markers linked with desirable characteristics.
 
Jean-Pierre Martinant, who heads a genotyping facility of Limagrain Verneuil Holding in France, said the collaboration with Cogenics and 454 “will significantly enhance our ability to accelerate the large scale genotyping campaigns required to meet the goals of this project.”
 
Financial terms of the agreement were not released.

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.